PNH Treatment Market: Advancing Targeted Therapies and Personalized Disease Management
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disorder characterized by the destruction of red blood cells, an increased risk of blood clots, and impaired blood cell production in some patients. The condition is associated with abnormalities in blood-forming stem cells that make red blood cells vulnerable to complement-mediated destruction. Treatment strategies aim to...
0 Σχόλια 0 Μοιράστηκε 2 Views 0 Προεπισκόπηση